High dose statins lower C reactive proteinBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7497.0-e (Published 21 April 2005) Cite this as: BMJ 2005;330:0-e
Question Is a lower C reactive protein level after aggressive treatment with statins associated with a lower risk of recurrent coronary events?
Synopsis This is a post hoc analysis of a randomised trial that compared atorvastatin (Lipitor) 80 mg with pravastatin (Pravachol) 40 mg in 4162 patients with acute coronary syndrome. Of those, 3745 had low density lipoprotein (LDL) and C reactive protein (CRP) levels measured 30 days after hospital discharge. There was a linear relationship between the reduction in LDL and the risk of recurrent coronary events (cardiovascular death or non-fatal myocardial …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial